Table: Kissei Pharm -Q1 group results

Kissei Pharmaceutical

31/07/2026 07:32

    Jul 31 (Reuters)- 
             Kissei Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             23.39               22.19            88.70    
                 (+5.4 pct)          (+4.9 pct)       (-8.9 pct)  
  Operating          1.10                2.11             2.00    
                 (-48.0 pct)         (-2.3 pct)                   
  Recurring          2.19                2.92             4.00    
                 (-25.0 pct)         (+1.4 pct)                   
  Net                4.72                4.52            13.30    
                 (+4.5 pct)          (+10.1 pct)      (-3.5 pct)  
  EPS            113.95 yen          107.88 yen       326.97 yen  
  Ann Div                            160.00 yen       170.00 yen  
  -Q2 div                             60.00 yen       105.00 yen  
  -Q4 div                            100.00 yen        65.00 yen  
  
  NOTE - Kissei Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4547.T